2C-F Stats & Data
NCCc1cc(OC)c(F)cc1OCQAVFEDRVOUKIPM-UHFFFAOYSA-NPharmacology
DrugBankDescription
At a dose of 250 milligrams, 2C-F produces modest closed-eye visuals accompanied by lethargy.
Mechanism of Action
Very little data exists about the pharmacological properties, metabolism, and toxicity of 2C-F.
Effect Profile
CuratedStrong visuals with moderate body load, mild headspace
Tolerance & Pharmacokinetics
drugs.wikiTolerance Decay
Model extrapolated from general serotonergic psychedelic tolerance patterns and reports for 2C‑B/2C‑T series; no direct PK/PD data for 2C‑F.
Cross-Tolerances
Harm Reduction
drugs.wikiIdentity and potency uncertainty is the primary harm‑reduction issue: 2C‑F is rare and reported as barely active; in grey markets it may be mis‑sold as other 2C‑x or even NBOMe/DOx compounds that are active at milligram or microgram levels. Use reagent kits as a first pass and, where available, submit to a lab drug‑checking service; do not escalate doses until identity is confirmed. Large single doses (hundreds of milligrams) raise cardiovascular strain (tachycardia, blood pressure) typical of phenethylamines; avoid stimulants, overheated venues, and dehydration. Onset can be delayed and subtle; redosing too early is a common cause of accidental over‑intoxication—wait at least 3–4 hours before considering any increase. Avoid lithium entirely: combinations with serotonergic psychedelics have precipitated seizures and severe reactions. Avoid tramadol/bupropion and MAOIs due to seizure and serotonergic risks. Tolerance to serotonergic psychedelics develops rapidly and decays over ~1–2 weeks; stacking trips compresses sleep, raises anxiety, and blunts subsequent responses. Because clinical pharmacokinetics are unknown, those with cardiovascular disease, epilepsy, or significant psychiatric comorbidity should abstain; if someone becomes overheated or confused, prioritize cooling, hydration with electrolytes, a calm environment, and seek medical help for chest pain, severe agitation, or seizures.
References
Drugs.wiki References
- Isomerdesign blog – The Halogenated 2Cs (2C‑F likely inactive or only weakly active >100 mg)
- Erowid – PiHKAL Chemical Story index (lists #26 2C‑F)
- Review of PiHKAL (table shows 2C‑F with ~250 mg notation)
- Bluelight CAS listing (confirms CAS 207740‑15‑6 for 2C‑F)
- Erowid – 2C‑B article (Nexus): typical phenethylamine cardiovascular effects (HR/BP rise)
- Erowid – LSD and Antidepressants (Lithium + psychedelics: seizure/death reports)
- Hi‑Ground (DanceWize) – Antidepressants: MAOI + 2C‑x/DOx caution
- Hi‑Ground – DMT combinations page (Tramadol lowers seizure threshold; psychedelic combinations caution)
- Saferparty.ch drug checking alerts (2C‑B tablets with impurities/mislabelling; illustrates impurity/mislabel risk in 2C‑x)
- Erowid/Trimbos DIMS infographic (LSD blotters often mis-sold as NBOMe/DOx; illustrates substitution risk)
- Bluelight NBOMe warning thread (misrepresentation dangers and severe reactions)
- Erowid – 2C‑B Basics (short tolerance; spacing 5–7+ days)